How decisions on the use of medicines and medical devices are made

Pharmaceutical Journal

Volumn 275, Issue 7364, 2005, Pages 254-256

  Garner, Sarah ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ACCESS TO INFORMATION; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; INTERMETHOD COMPARISON; INTERNET; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL INSTRUMENTATION; MEDICAL RESEARCH; NATIONAL HEALTH SERVICE; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PUBLIC OPINION; RESPONSIBILITY; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 24644522808     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. National Co-ordinating Centre for Health Technology Assessment. The NHS Health Technology Assessment Programme. Available at: www.ncchta.org/aboutHTA.htm (accessed 22 August 2005).
2. Oliver A,Mossialos E, Robinson R. Health technology assessment and its influence on health care priority setting. International Journal of Technology Assessment in Health Care 2004;20:1-10.
3. Department of Health. Assessing the effects of health technologies: principles, practise, proposals. London: Department of Health; 1992.
4. Department of Health. The NHS Plan: a plan for investment, a plan for reform. London: Department of Health; 2000.
5. Harman RJ. Legislation for Medicines and product liability - a review of UK and European Controls. Pharmaceutical Journal 2003;270:904-8.